loader2
Partner With Us NRI

Natural Capsules Ltd share Price Today

Company details

310.00
328.10
255.00
421.00
6M Return -15.57%
1Y Return -16.14%
Mkt Cap.(Cr) 301.46
Volume 19,049
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 19,049

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Natural Capsules Ltd shares SWOT Analysis

Strengths (4)

  • Company reducing Debt
  • Increasing Revenue every quarter for the past 2 quarters
  • Book Value per share Improving for last 2 years

Weakness (7)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Inefficient use of shareholder funds - ROE declining in the last 2 years
  • Inefficient use of assets to generate profits - ROA declining in the last 2 years

Opportunity (1)

  • RSI indicating price strength

Threats (3)

  • Companies with growing costs YoY for long term projects
  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 328.2
R2 337.2
R3 346.3
Pivot

319.10

S1 310.1
S2 301.0
S3 292.0
EMA SMA
310.6
312.4
321.9
340.9
306.9
312.7
320.3
342.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
PATTABIRAMAN R Bulk Purchase 2022-02-16 399.24 55000 BSE
PATTABIRAMAN R Bulk Purchase 2022-02-11 344.64 59615 BSE
VIVOG COMMERCIAL LIMITED Bulk Sell 2022-02-11 345.05 72578 BSE
Name Category Shares
SUNIL LAXMINARYAN MUNDRA PROMOTER 6.3%
SUSHIL KUMAR MUNDRA PROMOTER 5.44%
INDRA MUNDRA PROMOTER 4.19%
JYOTI MUNDRA PROMOTER 3.28%
SHARADA MUNDRA PROMOTER 2.83%
LAXMINARAYAN MOONDRA PROMOTER 2.57%
RADHA S MUNDRA PROMOTER 2.56%
SATYANARAYAN MUNDRA PROMOTER 1.98%
MADHAV MUNDRA PROMOTER 1.77%
SHREY MUNDRA PROMOTER 1.77%
TAJOS INVESTMENTS PRIVATE LIMITED PROMOTER 13.41%
NANDI SYNTHETICS PVT LTD PROMOTER 9.83%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Natural Capsules Ltd Stocks COMPARISON

Financials( in Cr) Natural Capsules Ltd Sun Pharmaceuticals Industries Ltd Divis Laboratories Ltd Cipla Ltd Zydus Lifesciences Ltd
Price 322.45 1,568.40 4,629.70 1,509.90 1,162.45
% Change 2.85 0.67 1.88 1.97 2.23
Mcap Cr 301.46 376,311.70 122,904.18 121,904.34 116,969.67
Revenue TTM Cr 155.42 43,885.68 7,767.51 15,790.60 17,237.40
Net Profit TTM Cr 5.55 8,560.84 1,823.38 2,513.47 1,997.30
PE TTM 53.65 37.61 76.78 28.63 30.34
1 Year Return -16.14 49.54 30.41 49.22 102.48
ROCE 5.00 16.79 19.30 14.76 16.25
ROE 3.39 16.46 14.89 10.66 14.05
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 203.80 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 32,034.54 42,550.31
LAST 3M 115,875.16 11,073.47
LAST 6M 199,586.16 4,620.47
LAST 12M 310,244.99 83,919.34

Natural Capsules Ltd Information

Stock PE (TTM)
53.65
Promoter Holding
56.56%
Book Value
218.3053
ROCE
5%
ROE
3.39%
Description
  • Natural Capsules Limited is a pharmaceutical company that manufactures hard dosage capsules, hard cellulose capsule shells, and pharmaceutical dosage forms. The company, founded in 1993, carries out manufacturing activities related to pharmaceutical products. Its registered office is in Bengaluru. The company meets all compliance and statutory requirements relating to cGLP and cGMP practices as ordained by the government of India.

    On 19 December 2022, the market capitalisation of the company was Rs 450.72 crore.  It reported a total income of Rs 45.13 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 890161 and not listed on the NSE.  

    Natural Capsules has a diversified shareholding pattern, with promoters holding approximately 56.56% of the company. The public has a stake of 42.2% in the company. FII and mutual funds do not hold any stake in the company (as of November 2022). The shareholding pattern of the company has remained largely stable over the past year.

    Sunil Laxminarayan Mundra is the current managing director of the company. Other directors of the company include CP Rangachar, Laxminarayan Mundra, Satyanarayana Mundra, Jyothi Mundra, Sushil Kumar Mundra, S G Belapure, and Pramod Kasat. The chief financial officer of Natural Capsules is R K Prasad. The company’s auditors are P Chandrasekar LLP.  

    On 19 December 2022, Natural Capsule’s share price was Rs 487.75 on the BSE. As mentioned earlier, the company is not listed on the National Stock Exchange. The company’s 52-week-high was Rs 679, while the 52-week-low was Rs 255. Its three-month return to investors was -16.05%, while its one-year return was 83.64%.

    The company’s peers include Fredun Pharma, Medico Remedies, and Fermenta Biotech.

    The total income of the company was Rs 45.13 crores during the quarter ended September 2022. The basic EPS of the company was 21.1 during the same time frame. The company’s total expenses were Rs 37.4 crore during that quarter. The company’s EBIT stood at Rs 7.73 crores, while the EBIT growth was 0.13%. The net profit margin was 11.7%.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

Trident Towers 4th Floor No 23, 100Feet Road Jayanagar IIBlock, Bangalore, Karnataka, 560011

Tel : 91-080-26671571/26671573/26671581
Email : company.sec:naturalcapsules.com; info:naturalcapsu
Website : http://www.naturalcapsules.com
Registrar

Cameo Corporate Services Ltd

AGM Date (Month) : Jul
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524654
NSE Code :
Book Closure Date (Month) : Jul
BSE Group : X
ISIN : INE936B01015

FAQ’s on Natural Capsules Ltd Shares

You can buy Natural Capsules Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Natural Capsules Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 05, 2024 04:01 PM the closing price of Natural Capsules Ltd was Rs.322.45.

The latest PE ratio of Natural Capsules Ltd as of Jul 05, 2024 04:01 PM is 53.65

The latest PB ratio of Natural Capsules Ltd as of Jul 05, 2024 04:01 PM is 0.68

The 52-week high of Natural Capsules Ltd share price is Rs. 421.00 while the 52-week low is Rs. 255.00

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 05, 2024 04:01 PM, the market cap of Natural Capsules Ltd stood at Rs. 301.46 Cr.

Download App

Download Our App

Play Store App Store
market app